Xeomin 200 unit vials
Ended Awarded
- Contract number
- SPE2DB26FX3FV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,229
Award facts
- Contract value 100% obligated
- $40,229.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $40,229.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 8, 2025, for the supply of 200-unit vials of Xeomin, a botulinum toxin-based pharmaceutical used for treating muscle spasticity and other neurological conditions. The contract, which is not set-aside and was competitively awarded, will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of October 30, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical vendor for federal medical procurement, particularly serving the Defense Health Agency and military healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to supply a wide range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This award reflects AmerisourceBergen's continued role as a primary supplier of specialty medications and branded pharmaceuticals to support Department of Defense medical operations and readiness requirements.
Quick answers
Who was awarded contract SPE2DB26FX3FV?
SPE2DB26FX3FV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 8, 2025.
How much is contract SPE2DB26FX3FV worth?
The government has obligated $40,229 on SPE2DB26FX3FV.
Is contract SPE2DB26FX3FV an order under another contract?
Yes. SPE2DB26FX3FV is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX3FV competed?
The extent of competition for SPE2DB26FX3FV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award